<p>There are 130 fully characterized patient cases with high risk Wilms tumor (all tumor/normal pairs; 8 with additional samples for analysis 3 with tumor adjacent normal, 5 with relapse sample)  that will make up the TARGET WT dataset. Each case will have gene expression, tumor and paired normal copy number analyses, methylation and whole</p>

TARGET: Kidney, Wilms Tumor (WT)

Wilms Tumor study with RNA-Seq, Targeted-Capture + 3 more data on CRDC (653 participants)